Literature DB >> 23552129

Aortic, but not brachial blood pressure category enhances the ability to identify target organ changes in normotensives.

Hendrik L Booysen1, Gavin R Norton, Muzi J Maseko, Carlos D Libhaber, Olebogeng H I Majane, Pinhas Sareli, Angela J Woodiwiss.   

Abstract

AIMS: We sought to determine whether within normal/high-normal blood pressure (BP) ranges (120-139/80-89 mmHg), aortic BP may further refine BP-related cardiovascular risk assessment, as determined from target organ changes.
METHODS: In 1169 participants from a community sample of African ancestry, 319 (27%) of whom had a normal/high-normal BP, aortic BP was determined using radial applanation tonometry and SphygmoCor software, and target organ changes assessed from carotid-femoral pulse wave velocity (PWV) (n = 1025), estimated glomerular filtration rate (eGFR) (n = 944), and left ventricular mass indexed to height (LVMI) (n = 690).
RESULTS: Normal versus high-normal BP categories failed to differentiate between those participants with a BP above optimal values with versus without multivariate-adjusted target organ changes. However, in those with a normal/high-normal BP with aortic SBP values that were less than 95% confidence interval of healthy participants with optimal BP values (45% of those with a normal/high-normal BP), no unadjusted or multivariate adjusted target organ changes were noted. In contrast, those with a normal/high-normal BP with aortic SBP values that exceeded optimal thresholds, demonstrated unadjusted and multivariate adjusted increases in PWV and LVMI and decreases in eGFR (P < 0.05 to P < 0.005 after multivariate adjustments).
CONCLUSION: In contrast to normal versus high-normal BP categories which do not clearly distinguish normotensives with from those without organ damage, noninvasively determined aortic BP measurements may refine the ability to detect those with a normal/high-normal BP at risk of BP-related cardiovascular damage.

Entities:  

Mesh:

Year:  2013        PMID: 23552129     DOI: 10.1097/HJH.0b013e328360802a

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Functional Organ Damage in Cardiovascular Low Risk Patients with High Central Aortic Pressure.

Authors:  Daniel Piskorz; Laureano Bongarzoni; Luciano Citta; Norberto Citta; Paula Citta; Luis Keller; Lucrecia Mata; Alicia Tommasi
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-05-27

Review 2.  Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to date.

Authors:  José Fernando Vilela-Martin
Journal:  Drug Des Devel Ther       Date:  2016-05-09       Impact factor: 4.162

3.  Risk Stratification by Cross-Classification of Central and Brachial Systolic Blood Pressure.

Authors:  Yi-Bang Cheng; Lutgarde Thijs; Lucas S Aparicio; Qi-Fang Huang; Fang-Fei Wei; Yu-Ling Yu; Jessica Barochiner; Chang-Sheng Sheng; Wen-Yi Yang; Teemu J Niiranen; José Boggia; Zhen-Yu Zhang; Katarzyna Stolarz-Skrzypek; Natasza Gilis-Malinowska; Valérie Tikhonoff; Wiktoria Wojciechowska; Edoardo Casiglia; Krzysztof Narkiewicz; Jan Filipovský; Kalina Kawecka-Jaszcz; Ji-Guang Wang; Yan Li; Jan A Staessen
Journal:  Hypertension       Date:  2022-03-04       Impact factor: 10.190

Review 4.  Central hypertension is a non-negligible cardiovascular risk factor.

Authors:  Yi-Bang Cheng; Yan Li; Hao-Min Cheng; Saulat Siddique; Minh Van Huynh; Apichard Sukonthasarn; Chen-Huan Chen; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09       Impact factor: 2.885

5.  Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study.

Authors:  Bryan Williams; John R Cockcroft; Kazuomi Kario; Dion H Zappe; Pamela Cardenas; Allen Hester; Patrick Brunel; Jack Zhang
Journal:  BMJ Open       Date:  2014-02-04       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.